Huntsville, Ala. — The HudsonAlpha Foundation has established the Memory and Mobility (M&M) Fund for neurological disease research.
The M&M fund will support HudsonAlpha Institute for Biotechnology’s current and future neurological disease research. The first project will be to sequence the genomes of 1,500 patients with Alzheimer and Alzheimer-related dementia.
“We have an unprecedented opportunity to access this data set and make new genomic discoveries in Alzheimer disease, which in turn will inform us about other neurodegenerative diseases such as ALS, Parkinson, and Huntington. These neurological diseases are all connected. Studying one of them will advance our understanding and knowledge of them all,” said Rick Myers, PhD, HudsonAlpha president and science director.
“We chose the name Memory and Mobility Fund because these diseases rob people of their memories or their mobility,” said Lynne Berry, executive director of the HudsonAlpha Foundation. “Using genomic science, HudsonAlpha researchers can find answers that will result in an improved quality of life for patients and their families.”